Search clinical trials for: AR101 (Characterized Peanut Allergen)

Total 739 results

Aimmune Therapeutics, Inc.

Completed

AR101 Real-World Open-Label Extension Study

Peanut Allergy

United States, Canada
Aimmune Therapeutics, Inc.

Completed

Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study

Peanut Allergy

United States
Aimmune Therapeutics, Inc.

Completed

PALISADE Follow-on Study (ARC004)

Peanut Allergy

United States, Spain, Netherlands, Italy, Canada, Germany, Ireland, Sweden, United Kingdom
Aimmune Therapeutics, Inc.

Terminated

Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents

Peanut Allergy

Spain
Aimmune Therapeutics, Inc.

Completed

Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) (RAMSES)

Peanut Allergy

United States, Canada
Aimmune Therapeutics, Inc.

Completed

Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

Peanut Allergy

United States, Canada, Spain, Netherlands, Germany, United Kingdom, Ireland, Sweden, France, Italy
Aimmune Therapeutics, Inc.

Completed

ARTEMIS Peanut Allergy In Children (ARTEMIS)

Peanut Allergy

United Kingdom, Italy, France, Germany, Ireland, Spain, Sweden
Aimmune Therapeutics, Inc.

Completed

Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)

Peanut Allergy

United States, United Kingdom, France, Germany
Aimmune Therapeutics, Inc.

Completed

Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT (ARC001)

Peanut Allergy

United States
Aimmune Therapeutics, Inc.

Completed

Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) (PALISADE)

Peanut Allergy

United States, Spain, Ireland, Netherlands, Canada, United Kingdom, Germany, Denmark, Italy, Sweden
Axovant Sciences Ltd.

Completed

Study Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET Study

Alzheimer's Disease

United States, Argentina, Australia, Bulgaria, Canada, Chile, Croatia, France, Germany, Italy, Korea, Republic of, Poland, Serbia, Singapore, Slovakia, Spain, Taiwan, United Kingdom, Czechia
Axovant Sciences Ltd.

Terminated

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

Alzheimer's Disease

United States, Argentina, Australia, Bulgaria, Canada, Chile, Croatia, Czechia, France, Germany, Italy, Korea, Republic of, Poland, Serbia, Singapore, Slovakia, Spain, Taiwan, United Kingdom
Celgene

Active, not recruiting

A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer

Small Cell Lung Carcinoma

France, Italy, Spain
Regeneron Pharmaceuticals
Sanofi; Aimmune Therapeutics, Inc.

Completed

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

Peanut Allergy

United States
Sykehuset Innlandet HF
Incen AG

Completed

Air Cleaners for Children and Adolescents With Asthma and Dog Allergy

Asthma | Allergy

Norway
Cubist Pharmaceuticals LLC

Completed

Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections

Complicated Urinary Tract Infection

United States, Germany, Poland
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Shanghai Public Health Clinical Center; Air Force Military Medical University... and other collaborators

Completed

Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10

Healthy
Pfizer

Completed

A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

Asthma

United Kingdom
Pfizer

Completed

A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects

Asthma

United Kingdom
Antigen Laboratories, Inc.

Completed

Phase 2 Study in Adults Sensitized to Cat

Allergy

United States
University Hospital, Montpellier
Hycor Biomedical

Terminated

Validation Study of NOVEOS® System (HYCOR) (HYCOR)

Allergen-mediated IgE Allergy

France
Lithuanian University of Health Sciences

Recruiting

Non-coding RNAs Analysis of Eosinophil Subtypes in Asthma

Allergic Asthma | Severe Eosinophilic Asthma

Lithuania
Scripps Health
The Scripps Research Institute

Withdrawn

Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

Food Allergy Peanut

United States
University Hospital, Montpellier

Completed

Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice (CHOICE)

Allergen Immunotherapy

France
Medical College of Wisconsin
Merck Sharp & Dohme LLC

Completed

Innate Immunity and the Allergic Response

Nasal Allergies
Hamilton Health Sciences Corporation

Completed

Role of Cigarette Smoking in Regulating Allergen-induced Early and Late Responses in Mild Asthmatics

Asthma

Canada
University of British Columbia

Completed

Effects of Co-Exposure to Air Pollution and Allergen

Allergies

Canada
Allerderm

Completed

Clinical Evaluation of Lyral® Dose Response Study

Contact Dermatitis

Denmark
McMaster University
St. Joseph's Healthcare Hamilton

Unknown

Repeat Dose Nasal Allergen Challenge

Allergic Rhinitis

Canada
Royal Brompton & Harefield NHS Foundation Trust

Recruiting

HDM and Silver Birch NAC Standardisation

Allergic Rhinitis

United Kingdom
JOSALYN CHO
Massachusetts General Hospital

Active, not recruiting

Airway Immune Response to Allergens (Use Lay Language Here)

Allergic Rhinitis | Allergic Conjunctivitis | Allergic Asthma | Allergy to Cats | Allergy to Dust Mites

United States
Red Maple Trials Inc.
Ottawa Allergy Research Corporation

Completed

Red Maple Trials Cat Allergen Natural Exposure Chamber Validation in Cat-allergic Subjects (NEC)

Allergic Rhinitis | Rhinoconjunctivitis | Exposure

Canada
Pfizer

Completed

A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.

Allergic Rhinitis

United States
GlaxoSmithKline

Completed

A Study To Evaluate The Safety, Tolerability And Pk Of Pazopanib Eye Drops In Healthy Adult And Elderly Subjects.

Macular Degeneration | Age-related Macular Degeneration

United States
Aytu BioPharma, Inc.
Parexel

Suspended

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome. (PREVEnt)

Vascular Ehlers-Danlos Syndrome

United States
Laval University
AllerGen NCE Inc.

Completed

Nasal Allergen Challenge in Rhinitic Subjects

Asthma | Allergic Rhinitis

Canada
National Institute of Allergy and Infectious Diseases...
Immune Tolerance Network (ITN)

Completed

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

Hypersensitivity, Immediate

Canada
Medical University of Silesia

Completed

House Dust Mite Injection Immunotherapy in Elderly Patients. (HDMeld)

Allergen Immunotherapy in Elderly Patients
Rigshospitalet, Denmark
TRYG Foundation

Completed

Study to Asses Efficacy of Intralymphatic Immunotherapy (ILIT)

Allergy

Denmark
University of Chicago

Terminated

Effect of Nasaleze on Nasal Challenge With Allergen

Allergic Rhinitis

United States
National Institute of Allergy and Infectious Diseases...
Inner-City Asthma Consortium

Terminated

Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults

Asthma | Allergy
McMaster University

Not yet recruiting

Measurements of Inflammation Induced by Allergen Inhalation Challenge in Mild Allergic Asthma (MATT)

Mild Asthma

Canada
University of British Columbia

Completed

Air Pollution and Allergens - Attenuation of Health Effects Particle Reduction (DE3)

Allergies

Canada
University of Zurich

Terminated

Phase II Study to Standardize Allergen Extracts: Determination of Biological Activity in HEP Units

Allergy

Switzerland
Laval University

Unknown

CysLT1-r Expression Following Allergen Exposure in Asthma and Allergic Rhinitis

Asthma | Allergic Rhinitis

Canada
Gachon University Gil Medical Center
Thermo Fisher Scientific, Inc

Completed

Pilot Study of Intralymphatic Immunotherapy (ILIT) for House Dust Mite, Cat, and Dog Allergen in Allergic Rhinitis (pILIT)

Allergic Rhinitis

Korea, Republic of
Alyatec

Completed

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Allergic Rhinitis | Rhinoconjunctivitis | Allergy to Pollen

France
Lesley Wong

Completed

Comparison of One-port and Two-port Tissue Expanders for Breast Reconstruction

Breast Cancer

United States
McMaster University
AllerGen NCE Inc.

Unknown

Canadian Peanut Thresholds Study

Peanut Allergy

Canada
Mansoura University Hospital

Completed

Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma (Sublingual)

Efficacy, Self

Egypt

Search clinical trials for: AR101 (Characterized Peanut Allergen)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations